LEVY RICHARD S sold 20.5% of their position (5.68K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.93M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−40.00
Price / share
$506.68
Trade value
$20.27K
% of position
Common Stock
Shares
−320.00
Price / share
$508.24
Trade value
$162.64K
% of position
Common Stock
Shares
−151.00
Price / share
$510.36
Trade value
$77.06K
% of position
Common Stock
Shares
−610.00
Price / share
$511.40
Trade value
$311.95K
% of position
Common Stock
Shares
−439.00
Price / share
$512.50
Trade value
$224.99K
% of position
Common Stock
Shares
−40.00
Price / share
$512.97
Trade value
$20.52K
% of position
Common Stock
Shares
−343.00
Price / share
$514.67
Trade value
$176.53K
% of position
Common Stock
Shares
−657.00
Price / share
$515.92
Trade value
$338.96K
% of position
Common Stock
Shares
−723.00
Price / share
$516.87
Trade value
$373.69K
% of position
Common Stock
Shares
−1.50K
Price / share
$517.59
Trade value
$774.84K
% of position
Common Stock
Shares
−782.00
Price / share
$518.76
Trade value
$405.67K
% of position
Common Stock
Shares
−80.00
Price / share
$519.98
Trade value
$41.60K
% of position
Net shares
−5.68K
Net value
-$2.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | S · Sale | −40.00 | $506.68 | $20.27K | 0.1% | 27.70K | 27.66K |
| Common Stock Direct | 5/22/2026 | S · Sale | −320.00 | $508.24 | $162.64K | 1.2% | 27.66K | 27.34K |
| Common Stock Direct | 5/22/2026 | S · Sale | −151.00 | $510.36 | $77.06K | 0.6% | 27.34K | 27.19K |
| Common Stock Direct | 5/22/2026 | S · Sale | −610.00 | $511.40 | $311.95K | 2.2% | 27.19K | 26.58K |
| Common Stock Direct | 5/22/2026 | S · Sale | −439.00 | $512.50 | $224.99K | 1.7% | 26.58K | 26.14K |
| Common Stock Direct | 5/22/2026 | S · Sale | −40.00 | $512.97 | $20.52K | 0.2% | 26.14K | 26.10K |
| Common Stock Direct | 5/22/2026 | S · Sale | −343.00 | $514.67 | $176.53K | 1.3% | 26.10K | 25.75K |
| Common Stock Direct | 5/22/2026 | S · Sale | −657.00 | $515.92 | $338.96K | 2.6% | 25.75K | 25.10K |
| Common Stock Direct | 5/22/2026 | S · Sale | −723.00 | $516.87 | $373.69K | 2.9% | 25.10K | 24.37K |
| Common Stock Direct | 5/22/2026 | S · Sale | −1.50K | $517.59 | $774.84K | 6.1% | 24.37K | 22.88K |
| Common Stock Direct | 5/22/2026 | S · Sale | −782.00 | $518.76 | $405.67K | 3.4% | 22.88K | 22.09K |
| Common Stock Direct | 5/22/2026 | S · Sale | −80.00 | $519.98 | $41.60K | 0.4% | 22.09K | 22.02K |
| Total | −5.68K | -$2.93M | ||||||